Cargando…
Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report
Background and case: An adolescent male presented with a second mediastinal tumor 1.5 years after treatment of a proven malignant germ-cell tumor in that location. The differential diagnosis included a recurrent germ-cell tumor or a non-germ cell malignancy. Serum tumor markers alpha-fetoprotein (AF...
Autores principales: | Hulsker, Caroline C. C., Kranendonk, Mariëtte E. G., Eleveld, Thomas F., Gillis, Ad J. M., van de Ven, Cornelis P., van Eijkelenburg, Natasha K. A., van der Kaaij, Niels P., van der Steeg, Alida F. W., Looijenga, Leendert H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431270/ https://www.ncbi.nlm.nih.gov/pubmed/34502216 http://dx.doi.org/10.3390/ijms22179310 |
Ejemplares similares
-
The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021) -
Treatment and Survival of Malignant Extracranial Germ Cell Tumours in the Paediatric Population: A Systematic Review and Meta-Analysis
por: Hulsker, Caroline C. C., et al.
Publicado: (2021) -
Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020) -
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
por: Lobo, João, et al.
Publicado: (2019) -
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2022)